Noninvasive assessment of ulcerative colitis activity in children
https://doi.org/10.46563/1560-9561-2021-24-1-12-19
EDN: yjvtky
Abstract
Timely diagnosis and monitoring of ulcerative colitis (UC) in children is extremely relevant. In recent years, much attention has been paid to improving noninvasive UC diagnosis methods, which are available and convenient in the practice of a doctor. In this regard, we analyzed the significance of changes in noninvasive laboratory parameters of sick children with different clinical and endoscopic UC activity.
Materials and methods. A prospective analysis of data of 80 patients diagnosed with UC at the age of 1 to 18 years with varying degrees of clinical and endoscopic activity of the disease was performed.
Results. Significant changes in the studied laboratory parameters’ levels were revealed depending on the degree of clinical and endoscopic UC activity in children. The changes in fecal calprotectin content, levels of albumin, hemoglobin, and platelets were particularly substantial and informative in the blood of sick children when comparing remission with moderate and high clinical and endoscopic UC activity. A decrease in platelet counts was also found when UC activity increased.
Conclusion. The studied laboratory parameters are informative noninvasive markers of UC activity in children. These indices can be used in the diagnosis of UC activity and monitoring of the course of the disease.
Contribution:
Tsvetkova V.S., Potapov A.S., Semikina E.L. — research concept and design;
Tsvetkova V.S., Anushenko A.O., Lokhmatov M.M., Kopyltsova E.A., Budkina T.N., Akulova S.S. — collection and processing of material;
Tsvetkova V.S., Semikina E.L., Surkov A.N. — statistical processing;
Tsvetkova V.S. — text writing;
Tsvetkova V.S., Fisenko A.P., Potapov A.S. — editing.
All co-authors — approval of the final version of the article, responsibility for the integrity of all parts of the article.
Acknowledgment. The study had no sponsorship.
Conflict of interest. The authors declare no conflict of interest.
Received: February 18, 2021
Accepted: February 22, 2021
Published: March 10, 2021
About the Authors
Valeriya S. TsvetkovaRussian Federation
MD, pediatrician, postgraduate student of the Gastroenterological department with the hepatological group of the National Medical Research Center of Children’s Health
e-mail: tsvetkova.valerie@gmail.com
Alexander S. Potapov
Russian Federation
Elena L. Semikina
Russian Federation
Andrey P. Fisenko
Russian Federation
Maksim M. Lokhmatov
Russian Federation
Andrey N. Surkov
Russian Federation
Anton O. Anushenko
Russian Federation
Elena A. Kopyltsova
Russian Federation
Tatyana N. Budkina
Russian Federation
Svetlana S. Akulova
Russian Federation
References
1. Knyazev O.V., Shkurko T.V., Kagramanova A.V., Veselov A.V., Nikonov E.L. Epidemiology of inflammatory bowel disease. State of the problem (review). Dokazatel’naya gastroenterologiya. 2020; 9(2): 66–73. https://doi.org/10.17116/dokgastro2020902166
2. Conrad M.A., Rosh J.R. Pediatric inflammatory bowel disease. Pediatr. Clin. North. Am. 2017; 64(3): 577-91. https://doi.org/10.1016/j.pcl.2017.01.005
3. Oliveira S.B., Monteiro I.M. Diagnosis and management of inflammatory bowel disease in children. BMJ. 2017; 357: j2083. https://doi.org/10.1136/bmj.j2083
4. Wilson D.C., Russell R.K. Overview of paediatric IBD. Semin. Pediatr. Surg. 2017; 26(6): 344-8. https://doi.org/10.1053/j.sempedsurg.2017.10.002
5. Dilillo D., Zuccotti G.V., Galli E., Meneghin F., Dell’Era A., Penagini F., et al. Noninvasive testing in the management of children with suspected inflammatory bowel disease. Scand. J. Gastroenterol. 2019; 54(5): 586-91. https://doi.org/10.1080/00365521.2019.1604799
6. Siow V.S., Bhatt R., Mollen K.P. Management of acute severe ulcerative colitis in children. Semin. Pediatr. Surg. 2017; 26(6): 367-72. https://doi.org/10.1053/j.sempedsurg.2017.10.006
7. Turner D., Otley A.R., Mack D., Hyams J., Bruijne J., Uusoue K., et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. 2007; 133(2): 423-32. https://orcid.org/10.1053/j.gastro.2007.05.029
8. Travis S.P., Schnell D., Krzeski P., Abreu M.T., Altman D.G., Colombel J.F., et al. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gut. 2012; 61(4): 535-42. https://doi.org/10.1136/gutjnl-2011-300486
9. Travis S.P., Schnell D., Krzeski P., Abreu M.T., Altman D.G., Colombel J.F., et al. Reliability and initial validation of the ulcerative colitis endoscopic index of severity. Gastroenterology. 2013; 145(5): 987-95. https://doi.org/10.1053/j.gastro.2013.07.024
10. Daperno M., Comberlato M., Bossa F., Biancone L., Bonanomi A., Cassinotti A., et al. Interobserver agreement in IBD scores requires expertise and education: Preliminary results from an ongoing IG-IBD study. Dig. Liver. Dis. 2011; 46(11): 969-73. https://doi.org/10.1016/j.dld.2014.07.010
11. Fuller M.K. Pediatric inflammatory bowel disease: special considerations. Surg. Clin. North. Am. 2019; 99(6): 1177-83. https://doi.org/10.1016/j.suc.2019.08.008
12. Maaser C., Sturm A., Vavricka S.R., Kucharzik T., Fiorino G., Annese V., et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J. Crohns Colitis. 2019; 13(2): 144-64. https://doi.org/10.1093/ecco-jcc/jjy113.
13. Öztürk Z.A., Dag M.S., Kuyumcu M.E., Cam H., Yesil Y., Yilmaz N., et al. Could platelet indices be new biomarkers for inflammatory bowel diseases? Eur. Rev. Med. Pharmacol. Sci. 2013; 17(3): 334-41.
14. Voudoukis E., Karmiris K., Koutroubakis I.E. Multipotent role of platelets in inflammatory bowel diseases: a clinical approach. World J. Gastroenterol. 2014; 20(12): 3180-90. https://doi.org/10.3748/wjg.v20.i12.3180
15. Aljomah G., Baker S.S., Schmidt K., Alkhouri R., Kozielski R., Zhu L., et al. Anemia in pediatric inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 2018; 67(3): 351-5. https://doi.org/10.1097/MPG.0000000000002002
16. Miller S.D., Cuffari C., Akhuemonkhan E., Guerrerio A.L., Lehmann H., Hutfless S. Anemia screening, prevalence, and treatment in pediatric inflammatory bowel disease in the United States, 2010-2014. Pediatr. Gastroenterol. Hepatol. Nutr. 2019; 22(2): 152-61. https://doi.org/10.5223/pghn.2019.22.2.152
17. Cioffi M., De Rosa A., Serao R., Picone I., Vietri M.T. Laboratory markers in ulcerative colitis: Current insights and future advances. World J. Gastrointest. Pathophysiol. 2015; 6(1): 13-22. https://doi.org/10.4291/wjgp.v6.i1.13
18. Matowicka-Karna J. Markers of inflammation, activation of blood platelets and coagulation disorders in inflammatory bowel diseases. Postepy. Hig. Med. Dosw. (Online). 2016; 70: 305-12. https://doi.org/10.5604/17322693.1199305
Review
For citations:
Tsvetkova V.S., Potapov A.S., Semikina E.L., Fisenko A.P., Lokhmatov M.M., Surkov A.N., Anushenko A.O., Kopyltsova E.A., Budkina T.N., Akulova S.S. Noninvasive assessment of ulcerative colitis activity in children. Russian Pediatric Journal. 2021;24(1):12-19. (In Russ.) https://doi.org/10.46563/1560-9561-2021-24-1-12-19. EDN: yjvtky